5/13
05:13 pm
dcph
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGS, HCP, DCPH
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGS, HCP, DCPH
5/10
10:59 am
dcph
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates Fri, May 10, 2024, 2:50 PM GMT+2 3 min read 0 In this article: Advertisement Up next Analyst adjusts Nvidia stock price target ahead of earnings Fri, May 10, 2024, 1:03 AM GM
Low
Report
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates Fri, May 10, 2024, 2:50 PM GMT+2 3 min read 0 In this article: Advertisement Up next Analyst adjusts Nvidia stock price target ahead of earnings Fri, May 10, 2024, 1:03 AM GM
5/10
10:59 am
dcph
Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings [Yahoo! Finance]
Low
Report
Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings [Yahoo! Finance]
5/9
02:30 pm
dcph
SHAREHOLDER ALERT: Weiss Law Investigates Deciphera Pharmaceuticals, Inc.
Low
Report
SHAREHOLDER ALERT: Weiss Law Investigates Deciphera Pharmaceuticals, Inc.
5/4
09:24 am
dcph
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, DPSI, UNIT
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, DPSI, UNIT
5/3
08:33 pm
dcph
Lifshitz Law PLLC Announces Investigations of DCPH, SLCA, HCP, and HTLF
Low
Report
Lifshitz Law PLLC Announces Investigations of DCPH, SLCA, HCP, and HTLF
5/2
12:34 pm
dcph
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, DCPH, HTLF, TBNK
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, DCPH, HTLF, TBNK
5/2
11:44 am
dcph
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More [Yahoo! Finance]
Neutral
Report
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More [Yahoo! Finance]
5/1
06:13 pm
dcph
DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPH
Low
Report
DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPH
5/1
07:37 am
dcph
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) was downgraded by analysts at Leerink Partnrs from an "outperform" rating to a "market perform" rating.
Low
Report
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) was downgraded by analysts at Leerink Partnrs from an "outperform" rating to a "market perform" rating.
4/30
03:22 pm
dcph
XBI: The 2 Things Biotech Needs To Move Higher [Seeking Alpha]
Low
Report
XBI: The 2 Things Biotech Needs To Move Higher [Seeking Alpha]
4/30
01:30 pm
dcph
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, UMBF, TBNK
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, UMBF, TBNK
4/30
01:19 pm
dcph
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its "neutral" rating re-affirmed by analysts at Guggenheim.
Low
Report
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its "neutral" rating re-affirmed by analysts at Guggenheim.
4/30
12:10 pm
dcph
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its "market perform" rating re-affirmed by analysts at JMP Securities.
Low
Report
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its "market perform" rating re-affirmed by analysts at JMP Securities.
4/30
09:07 am
dcph
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $26.00 price target on the stock, up previously from $9.00.
Low
Report
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $26.00 price target on the stock, up previously from $9.00.
4/30
07:10 am
dcph
ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals [Yahoo! Finance]
Low
Report
ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals [Yahoo! Finance]
4/30
07:00 am
dcph
ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals
Low
Report
ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals
4/29
07:39 pm
dcph
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, HCP
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, HCP
4/29
05:59 pm
dcph
INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Deciphera Pharmaceuticals, Inc. - DCPH
Low
Report
INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Deciphera Pharmaceuticals, Inc. - DCPH
4/29
03:50 pm
dcph
Janux Therapeutics jumps as much as 28% on heels of Deciphera buyout deal [Seeking Alpha]
Low
Report
Janux Therapeutics jumps as much as 28% on heels of Deciphera buyout deal [Seeking Alpha]
4/29
02:19 pm
dcph
Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday? [Yahoo! Finance]
Low
Report
Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday? [Yahoo! Finance]
4/29
12:29 pm
dcph
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates DCPH, HTLF, UMBF, HCP
Low
Report
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates DCPH, HTLF, UMBF, HCP
4/29
11:32 am
dcph
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its "hold" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $25.60 price target on the stock, down previously from $26.00.
Low
Report
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its "hold" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $25.60 price target on the stock, down previously from $26.00.
4/29
11:32 am
dcph
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its "hold" rating re-affirmed by analysts at Jonestrading. They now have a $25.60 price target on the stock.
Low
Report
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its "hold" rating re-affirmed by analysts at Jonestrading. They now have a $25.60 price target on the stock.
4/29
10:30 am
dcph
Shareholder Alert: Ademi LLP investigates whether Deciphera Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with ONO Pharmaceutical Co.
Low
Report
Shareholder Alert: Ademi LLP investigates whether Deciphera Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with ONO Pharmaceutical Co.